Effect of Chronic Antipsychotic Treatment on Brain Structure: A Serial Magnetic Resonance Imaging Study with Ex Vivo and Postmortem Confirmation

BACKGROUND There is increasing evidence that antipsychotic (APD) may affect brain structure directly. To examine this, we developed a rodent model that uses clinically relevant doses and serial magnetic resonance imaging (MRI), followed by postmortem histopathological analysis to study the effects of APD on brain structures. METHODS Antipsychotic , haloperidol, and olanzapine were continuously administered to rats via osmotic minipumps to maintain clinic-like steady state levels for 8 weeks. Longitudinal in vivo MRI scanning (T₂-weighted) was carried out at baseline, 4 weeks, and 8 weeks, after which animals were perfused and their brains preserved for ex vivo MRI scanning. Region of interest analyses were performed on magnetic resonance images (both in vivo as well as ex vivo) along with postmortem stereology using the Cavalieri estimator probe. RESULTS Chronic (8 weeks) exposure to both haloperidol and olanzapine resulted in significant decreases in whole-brain volume (6% to 8%) compared with vehicle-treated control subjects, driven mainly by a decrease in frontal cerebral cortex volume (8% to 12%). Hippocampal, corpus striatum, lateral ventricles, and corpus callosum volumes were not significantly different from control subjects, suggesting a differential effect of APD on the cortex. These results were corroborated by ex vivo MRI scans and decreased cortical volume was confirmed postmortem by stereology. CONCLUSIONS This is the first systematic whole-brain MRI study of the effects of APD, which highlights significant effects on the cortex. Although caution needs to be exerted when extrapolating results from animals to patients, the approach provides a tractable method for linking in vivo MRI findings to their histopathological origins.

[1]  Charlton Cheung,et al.  A naturalistic study of grey matter volume increase after early treatment in anti-psychotic naïve, newly diagnosed schizophrenia , 2009, Psychopharmacology.

[2]  R. Kahn,et al.  Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. , 2002, Archives of general psychiatry.

[3]  S. Borgwardt,et al.  The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia? , 2009, Psychological Medicine.

[4]  S. Kapur,et al.  “Breakthrough” Dopamine Supersensitivity during Ongoing Antipsychotic Treatment Leads to Treatment Failure over Time , 2007, The Journal of Neuroscience.

[5]  The neuropathology of schizophrenia. , 1999, Journal of neuropathology and experimental neurology.

[6]  P. Herbison,et al.  Safety and Usage of Atypical Antipsychotic Medicines in Children , 2007, Drug safety.

[7]  H. Gundersen,et al.  Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.

[8]  M Ashtari,et al.  Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. , 1992, Archives of general psychiatry.

[9]  John Suckling,et al.  Different Effects of Typical and Atypical Antipsychotics on Grey Matter in First Episode Psychosis: the ÆSOP Study , 2005, Neuropsychopharmacology.

[10]  J. Suckling,et al.  Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment , 2008, Psychological Medicine.

[11]  L. Selemon,et al.  Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease. , 2001, Schizophrenia bulletin.

[12]  K. Jellinger,et al.  The neuropathology of schizophrenia. , 1999, Journal of neuropathology and experimental neurology.

[13]  Paul M. Thompson,et al.  Detection, visualization and animation of abnormal anatomic structure with a deformable probabilistic brain atlas based on random vector field transformations , 1997, Medical Image Anal..

[14]  S. Kapur,et al.  The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study , 1997, Psychopharmacology.

[15]  Allan R. Sampson,et al.  Effect of Chronic Antipsychotic Exposure on Astrocyte and Oligodendrocyte Numbers in Macaque Monkeys , 2008, Biological Psychiatry.

[16]  A. Janowsky,et al.  Effects of Subchronic Clozapine and Haloperidol on Striatal Glutamatergic Synapses , 1996, Journal of neurochemistry.

[17]  M. Modo,et al.  Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease , 2010, BMC Neuroscience.

[18]  B. Bradbury,et al.  Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study. , 2003, British journal of clinical pharmacology.

[19]  R Kono,et al.  Antibody titres to enterovirus type 70 in the 1981 Indian epidemic of acute haemorrhagic conjunctivitis. , 1981, Lancet.

[20]  T. Crow,et al.  CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA , 1976, The Lancet.

[21]  T. Crow,et al.  Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. , 1989, Archives of general psychiatry.

[22]  B. Pakkenberg,et al.  Post-mortem Study of Chronic Schizophrenic Brains , 1987, British Journal of Psychiatry.

[23]  Brain volume changes in schizophrenia: how do they arise? what do they mean? , 2009, Psychological Medicine.

[24]  J. Lieberman,et al.  Striatal enlargement in rats chronically treated with neuroleptic , 1998, Biological Psychiatry.

[25]  P. Dazzan,et al.  Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings , 2009, Psychological Medicine.

[26]  Philip K. McGuire,et al.  Regional Gray Matter Volume Abnormalities in the At Risk Mental State , 2007, Biological Psychiatry.

[27]  W. Hill,et al.  Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats , 2002, Psychopharmacology.

[28]  J. Lieberman,et al.  Antipsychotic drug effects on brain morphology in first-episode psychosis. , 2005, Archives of general psychiatry.

[29]  Richard Coppola,et al.  Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment , 2006, Psychiatry Research: Neuroimaging.

[30]  J. Lieberman,et al.  Longitudinal study of brain morphology in first episode schizophrenia , 2001, Biological Psychiatry.

[31]  J N Giedd,et al.  Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. , 1996, The American journal of psychiatry.

[32]  W. Honer,et al.  Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. , 2004, The American journal of psychiatry.

[33]  N. Andreasen,et al.  Ventricular enlargement in schizophrenia: definition and prevalence. , 1982, The American journal of psychiatry.

[34]  M. D. de Leon,et al.  Volumetric measurement of the hippocampus, the anterior cingulate cortex, and the retrosplenial granular cortex of the rat using structural MRI. , 2002, Brain research. Brain research protocols.

[35]  Alan A. Wilson,et al.  5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. , 1998, The American journal of psychiatry.

[36]  M. Swartz,et al.  Who are the new users of antipsychotic medications? , 2008, Psychiatric services.

[37]  Robert J. McMahon,et al.  The Relationship of Clozapine and Haloperidol Treatment Response to Prefrontal, Hippocampal, and Caudate Brain Volumes , 2003 .

[38]  B. Bogerts,et al.  Recent advances in the neuropathology of schizophrenia. , 1993, Schizophrenia bulletin.

[39]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[40]  J. Lieberman,et al.  Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. , 1994, The American journal of psychiatry.

[41]  Manzar Ashtari,et al.  Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine , 1995, The Lancet.

[42]  Nick C Fox,et al.  Computer-assisted imaging to assess brain structure in healthy and diseased brains , 2003, The Lancet Neurology.

[43]  Patricia Desmond,et al.  A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia , 2001, Schizophrenia Research.

[44]  Paul J. Harrison The neuropathological effects of antipsychotic drugs , 1999, Schizophrenia Research.

[45]  Daniel R Weinberger,et al.  Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? , 2002, Archives of general psychiatry.

[46]  Joseph V Hajnal,et al.  A serial longitudinal quantitative MRI study of cerebral changes in first-episode schizophrenia using image segmentation and subvoxel registration , 2001, Psychiatry Research: Neuroimaging.

[47]  Tyrone D. Cannon,et al.  A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. , 1998, Archives of general psychiatry.

[48]  S. Kapur,et al.  Half a century of antipsychotics and still a central role for dopamine D2 receptors , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[49]  S. Heckers,et al.  Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems. , 1997, Schizophrenia bulletin.

[50]  A. Carlsson,et al.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.

[51]  D. Braus,et al.  Die Wirkung von Antipsychotika auf glutamaterge Neurotransmission im Tiermodell , 2004, Der Nervenarzt.

[52]  A. Sampson,et al.  Effect of Chronic Exposure to Antipsychotic Medication on Cell Numbers in the Parietal Cortex of Macaque Monkeys , 2007, Neuropsychopharmacology.

[53]  D. Quartermain,et al.  The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and eighteen-month-old rats , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[54]  J. Lieberman,et al.  Time-lapse mapping of cortical changes in schizophrenia with different treatments. , 2009, Cerebral cortex.

[55]  Guido Gerig,et al.  Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia , 2005, British Journal of Psychiatry.

[56]  D. Weinberger,et al.  Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment , 2008, Schizophrenia Research.

[57]  D. Braus,et al.  Hippocampal volume and cell proliferation after acute and chronic clozapine or haloperidol treatment , 2004, Journal of Neural Transmission.

[58]  Zhuoxin Sun,et al.  The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys , 2005, Neuropsychopharmacology.

[59]  A. Malla,et al.  First-episode psychosis: psychopathology, quality of life, and functional outcome. , 2005, Schizophrenia bulletin.

[60]  S. Kapur,et al.  Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy , 2003, Journal of Pharmacology and Experimental Therapeutics.

[61]  H J Gundersen,et al.  The efficiency of systematic sampling in stereology and its prediction * , 1987, Journal of microscopy.

[62]  Francine M. Benes,et al.  The effects of haloperidol on synaptic patterns in the rat striatum , 1985, Brain Research.

[63]  D. Mikulis,et al.  Volumetric MRI measurement of caudate nuclei in antipsychotic-naive patients suffering from a first episode of psychosis. , 2005, Journal of psychiatric research.

[64]  Robert Quinn,et al.  Comparing rat's to human's age: how old is my rat in people years? , 2005, Nutrition.

[65]  I. Weiner,et al.  Clozapine Administration in Adolescence Prevents Postpubertal Emergence of Brain Structural Pathology in an Animal Model of Schizophrenia , 2009, Biological Psychiatry.

[66]  C. Haw,et al.  Off-label use of antipsychotics: are we mad? , 2007, Expert opinion on drug safety.

[67]  S. Kapur,et al.  The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats , 2002, Psychopharmacology.

[68]  L. Magder,et al.  Psychotropic practice patterns for youth: a 10-year perspective. , 2003, Archives of pediatrics & adolescent medicine.

[69]  C. Pantelis,et al.  Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis , 2009, Schizophrenia Research.

[70]  R. Kahn,et al.  The Effect of Clozapine on Caudate Nucleus Volume in Schizophrenic Patients Previously Treated with Typical Antipsychotics , 2001, Neuropsychopharmacology.

[71]  Angelo Bifone,et al.  A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: Application to pharmacological MRI , 2006, NeuroImage.

[72]  L. L. Porter,et al.  Local application of dopamine inhibits pyramidal tract neuron activity in the rodent motor cortex. , 2002, Journal of neurophysiology.

[73]  R Jagoe,et al.  Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. , 1986, Archives of general psychiatry.

[74]  Carme Junqué,et al.  Volume Changes in Gray Matter in First-Episode Neuroleptic-Naive Schizophrenic Patients Treated With Risperidone , 2005, Journal of clinical psychopharmacology.

[75]  M. Keshavan,et al.  Changes in caudate volume with neuroleptic treatment , 1994, The Lancet.

[76]  Dennis Velakoulis,et al.  Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. , 2009, Archives of general psychiatry.

[77]  T. Crow,et al.  Schizophrenia and the brain: a prospective clinico-neuropathological study , 1990, Psychological Medicine.

[78]  L. DeLisi,et al.  A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: Preliminary findings , 1995, Biological Psychiatry.

[79]  Andreas Meyer-Lindenberg,et al.  Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits , 2010, Nature Neuroscience.

[80]  S. Heckers,et al.  Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia , 2001, Biological Psychiatry.

[81]  R. Gainetdinov,et al.  The Akt-GSK-3 signaling cascade in the actions of dopamine. , 2007, Trends in pharmacological sciences.